Genomic characterization efforts in small-cell lung cancer have been complicated by the paucity of high-quality surgical resection specimens for this aggressive lung cancer subtype that is usually diagnosed at unresectable stages in small biopsies or cytology specimens. Now, two papers report genomic analyses of small-cell lung cancer, highlighting subsets of tumors driven by amplification of FGFR1, SOX2 or MYC family members or by a MYCL1 fusion oncogene, among many other recurrent alterations.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Nature Communications Open Access 17 November 2021
-
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Nature Communications Open Access 14 September 2021
-
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Oncogenesis Open Access 05 August 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chute, J.P., Chen, T., Feigal, E., Simon, R. & Johnson, B.E. J. Clin. Oncol. 17, 1794–1801 (1999).
Rudin, C.M. et al. Nat. Genet. 44, 1111–1116 (2012).
Peifer, M. et al. Nat. Genet. 44, 1104–1110 (2012).
Pao, W., Iafrate, A.J. & Su, Z. J. Pathol. 223, 230–240 (2011).
Weiss, J. et al. Sci. Transl. Med. 2, 62ra93 (2010).
The Cancer Genome Atlas Research Network. Nature published online; doi:10.1038/nature11404 (9 September 2012).
Pleasance, E.D. et al. Nature 463, 184–190 (2010).
Mäkela, T.P., Saksela, K., Evan, G. & Alitalo, K. EMBO J. 10, 1331–1335 (1991).
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Tompkins, D.H. et al. PLoS One 4, e8248 (2009).
Chen, S. et al. PLoS One 7, e36326 (2012).
Pardo, O.E. et al. Cancer Res. 69, 8645–8651 (2009).
Bass, A.J. et al. Nat. Genet. 41, 1238–1242 (2009).
Rekhtman, N. Arch. Pathol. Lab. Med. 134, 1628–1638 (2010).
Rekhtman, N. et al. Clin. Cancer Res. 18, 1167–1176 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Past and Current Clinical trials of Targeted Agents in SCLC (PDF 29 kb)
Rights and permissions
About this article
Cite this article
Pietanza, M., Ladanyi, M. Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet 44, 1074–1075 (2012). https://doi.org/10.1038/ng.2415
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2415
This article is cited by
-
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Nature Communications (2021)
-
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Nature Communications (2021)
-
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung
Journal of Cancer Research and Clinical Oncology (2015)
-
Smoking, inflammation and small cell lung cancer: recent developments
Wiener Medizinische Wochenschrift (2015)
-
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Oncogenesis (2013)
